Atlas Trials

Childhood Central Nervous System Choriocarcinoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Childhood Central Nervous System Choriocarcinoma

RecordFirmDate
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01088763)National Cancer Institute (NCI)2010-03-01
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors (NCT01076530)National Cancer Institute (NCI)2010-02-01
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma (NCT00994500)National Cancer Institute (NCI)2009-08-01
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment (NCT00929903)National Cancer Institute (NCI)2009-06-01
Sunitinib in Treating Young Patients With Refractory Solid Tumors (NCT00387920)National Cancer Institute (NCI)2006-10-01
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors (NCT00281944)National Cancer Institute (NCI)2005-09-01

Track Childhood Central Nervous System Choriocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.